BeStock  
Stocks › Biotechnology › REGN

Regeneron Pharmaceuticals REGN

US equityMarket cap rank #226BiotechnologyInfectious Disease
$904.35 +$1.45 (+0.16%)
Market closed · Nov 7, 9:50 pm ET · Last extended-hours $900.00 -0.48%
Open$887.22
Prev close$902.90
Day range$887.04 – $911.64
Volume1.12M
Market cap$93.55B
P/E (TTM)20.0
Dividend yield0.41%

Analyst view

ConsensusBuy
Analysts23
Average target$959.57+6.1% vs. price
  • Buy 70%
  • Hold 30%
Low $761.00Now $904.35Avg $959.57High $1,175.00

Recent rating changes

The last 20 actions on file set price targets from $810.00 to $1,175.00, averaging $967.60.

DateFirmRatingTarget
2 Nov 2026 CCORF BUY $1,175.00
2 Nov 2026 UBS BUY $1,068.00
2 Nov 2026 Truist Financial BUY $982.00
2 Nov 2026 BMO Capital BUY $1,050.00
2 Nov 2026 Guggenheim BUY $1,100.00
2 Nov 2026 Leerink Partners HOLD $997.00
1 Nov 2026 Cantor Fitzgerald BUY $980.00
30 Oct 2026 Wells Fargo HOLD $925.00
30 Oct 2026 Piper Sandler BUY $1,000.00
30 Oct 2026 Raymond James BUY $1,020.00
30 Oct 2026 BofA Securities BUY $1,030.00
30 Oct 2026 Morgan Stanley HOLD $855.00
30 Oct 2026 Citi HOLD $825.00
30 Oct 2026 RBC Capital HOLD $913.00
30 Oct 2026 J.P. Morgan BUY $1,050.00
28 Oct 2026 CCORF BUY $922.00
27 Oct 2026 RBC Capital HOLD $810.00
21 Oct 2026 TD Cowen BUY $980.00
21 Oct 2026 Leerink Partners HOLD $835.00
20 Oct 2026 Leerink Partners HOLD $835.00

Discussion

No comments yet — be the first to weigh in on REGN.

Sign in to join the discussion.

Scroll to Top